The CDC has now released booster guidance for all three vaccines available in the U.S. — making tens of millions of people eligible for another shot. And on Tuesday, an FDA panel met to review data from Pfizer on their vaccine for children ages 5 – 11.
NPR’s Alison Aubrey explains what those data say about the vaccine — and how it might be rolled out.
Pediatrician Dr. Reah Boyd tells NPR how she’s talking to parents about vaccinating their young children.
Additional reporting in this episode from NPR’s Pien Huang, Rob Stein, and Selena Simmons-Duffin.
Email us at considerthis@npr.org.